{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:18:22Z","timestamp":1769750302267,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI093369"],"award-info":[{"award-number":["R01AI093369"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI083045"],"award-info":[{"award-number":["U01AI083045"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI093666"],"award-info":[{"award-number":["R01AI093666"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.virol.2014.10.025","type":"journal-article","created":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T08:45:16Z","timestamp":1416386716000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFN\u03b3"],"prefix":"10.1016","volume":"474","author":[{"given":"Darryll A.","family":"Barkhouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milosz","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Craig","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2014.10.025_bib19","series-title":"Modification of the Immune Response to Ovalbumin Expressed by a Rabies Virus Vector","author":"Badiane","year":"2011"},{"key":"10.1016\/j.virol.2014.10.025_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/iai.12.1.98-103.1975","article-title":"Prolonging morbidity in rabid dogs by intrathecal injection of attenuated rabies vaccine","volume":"12","author":"Baer","year":"1975","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2014.10.025_bib501","article-title":"Expression of IFN\u03b3 by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon","author":"Barkhouse","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"Conzelmann","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.10.025_bib13","first-page":"50","article-title":"Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis","volume":"3","author":"Dietzschold","year":"2000","journal-title":"J. Hum. Virol"},{"key":"10.1016\/j.virol.2014.10.025_bib27","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib9","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib14","doi-asserted-by":"crossref","first-page":"15405","DOI":"10.1128\/JVI.79.24.15405-15416.2005","article-title":"Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice","volume":"79","author":"Faber","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib10","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1128\/JVI.00357-07","article-title":"Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus","volume":"81","author":"Faber","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib6","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0905640106","article-title":"Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus","volume":"106","author":"Faber","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.virol.2014.10.025_bib3","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1016\/j.vaccine.2009.09.034","article-title":"Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines","volume":"27","author":"Franka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.10.025_bib31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/jvi.71.2.866-872.1997","article-title":"Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques","volume":"71","author":"Giavedoni","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib16","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1523\/JNEUROSCI.17-11-04170.1997","article-title":"Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction","volume":"17","author":"Gomez","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.virol.2014.10.025_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-009-8143-4","article-title":"Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons","volume":"47","author":"Griffin","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virol.2014.10.025_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2011.04.001","article-title":"Interferon-\u03b3 influences immunity elicited by vaccines against very virulent Marek\u05f3s disease virus","volume":"90","author":"Haq","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2014.10.025_bib20","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/JVI.72.5.3711-3719.1998","article-title":"Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system","volume":"72","author":"Hooper","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/fvl.10.88","article-title":"Therapeutic immune clearance of rabies virus from the CNS","volume":"6","author":"Hooper","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/B978-0-12-387040-7.00017-2","article-title":"Therapy of human rabies","volume":"79","author":"Jackson","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2014.10.025_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.vaccine.2013.10.067","article-title":"Determinants of delay in initiating post-exposure prophylaxis for rabies prevention among animal bite cases: hospital based study","volume":"32","author":"Joseph","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.10.025_bib2","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.virol.2014.10.025_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.vaccine.2007.10.072","article-title":"Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NF\u03baB signaling pathway","volume":"26","author":"Li","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2014.10.025_bib7","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/JVI.06699-11","article-title":"Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the central nervous system (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib28","doi-asserted-by":"crossref","first-page":"e87105","DOI":"10.1371\/journal.pone.0087105","article-title":"A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virol.2014.10.025_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0042-6822(62)90290-8","article-title":"Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence","volume":"16","author":"Macpherson","year":"1962","journal-title":"Virology"},{"key":"10.1016\/j.virol.2014.10.025_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1201-9712(00)90114-0","article-title":"Global infectious disease surveillance","volume":"4","author":"Martinez","year":"2000","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2014.10.025_bib26","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1128\/JVI.76.9.4497-4506.2002","article-title":"Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent","volume":"76","author":"Patterson","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib21","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.4049\/jimmunol.176.12.7666","article-title":"Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system","volume":"176","author":"Phares","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2014.10.025_bib22","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.4049\/jimmunol.178.11.7334","article-title":"A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient","volume":"178","author":"Phares","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2014.10.025_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s003350010149","article-title":"Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice","volume":"11","author":"Rafael","year":"2000","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.virol.2014.10.025_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/08828240260066206","article-title":"Effects of interferon-\u03b3 on neuronal infections","volume":"15","author":"Rottenberg","year":"2002","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virol.2014.10.025_bib12","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2014.10.025_bib8","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JVI.02589-12","article-title":"Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies","volume":"87","author":"Schutsky","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.025_bib18","series-title":"Laboratory Techniques in Rabies,","year":"1996"},{"key":"10.1016\/j.virol.2014.10.025_bib32","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2014.10.025_bib34","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.vaccine.2011.03.104","article-title":"Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies","volume":"29","author":"Wu","year":"2011","journal-title":"Vaccine"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214004826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214004826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:29:51Z","timestamp":1758587391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682214004826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":35,"alternative-id":["S0042682214004826"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2014.10.025","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFN\u03b3","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2014.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}